Continuing anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy is associated with a lower likelihood of relapse of inflammatory bowel disease (IBD) in pregnant women and fewer ...
Approximately 8 out of every 1,000 newborns are affected by a congenital heart defect. CHDs remain the most common type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results